Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levothyroxine for Cardio-metabolic Risk in Children with Subclinical Hypothyroidism
NCT04178928Phase 2Unknown
- Sponsor
- Ain Shams University
- Start
- Jan 2020
- Primary completion
- Jan 2021
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, open-label trial of levothyroxine sodium in hypothyroidism, sponsored by Ain Shams University. Primary endpoint: Normalization of TSH at 12 weeks. Status: unknown.
02
Drugs
levothyroxine sodium
03
Conditions
hypothyroidism
Beyond the preview
Go deeper on NCT04178928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04178928.